Harrow Health, Inc. (HROW) stock analysis

In our weekly check, Harrow Health, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 11 pass, warnings: 3, red flags: 8.

Sector: Healthcare · Drug Manufacturers—Specialty & Generic

Strengths

• Margins rising
• Profits backed by cash
• Strong free cash flow

Warning signs

• High debt
• Weak interest cover
• Weak EPS growth
• Thin margins
• Very volatile

Next earnings report: 2026-11-09

Similar companies

AMPH · PCRX · ETON · COLL · ANIP · IRWD

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-10

Open the full analysis